Treating hypertension in diabetic nephropathy.

Area of Science:

• Nephrology
• Cardiology
• Endocrinology

Background:

• Hypertension control in diabetic nephropathy is crucial for improving mortality and slowing kidney disease progression.
• Managing blood pressure in these patients is complex, often necessitating combination drug therapy.
• Established treatment algorithms for hypertension in diabetic nephropathy are lacking.

Purpose of the Study:

• To evaluate a stepped-care algorithm for hypertension management in patients with diabetic nephropathy.
• To assess the achievement of American Diabetes Association blood pressure targets (<130/80 mmHg) using this algorithm.
• To determine the efficacy of ACE inhibitor or ARB-centered therapy in this patient group.

Main Methods:

• A prospective study involving 49 patients with diabetes (type 1 and type 2) and diabetic nephropathy.
• Patients received treatment via a stepped-care algorithm, prioritizing maximum doses of ACE inhibitors or ARBs.
• Blood pressure control was assessed at follow-up, with a median duration of 18 months.

Main Results:

• Mean blood pressure achieved was 140/75 mmHg for type 1 and 146/76 mmHg for type 2 diabetes.
• Only 33% of patients reached the target blood pressure goal.
• Systolic blood pressure remained above target in the majority of patients, irrespective of baseline characteristics.

Conclusions:

• A stepped-care algorithm can achieve blood pressure control comparable to clinical trials in diabetic nephropathy.
• Despite aggressive multi-drug therapy, achieving target systolic blood pressure remains a significant challenge in this population.
• Further strategies may be needed to optimize hypertension management in patients with diabetic nephropathy.